Quick Answer
ABBOTT LABORATORIES reported R&D Expense of $2.94 billion for fiscal year 2025.
ABBOTT LABORATORIES R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.94B | +3.4% |
| 2024 | $2.84B | +3.8% |
| 2023 | $2.74B | -5.1% |
| 2022 | $2.89B | +5.3% |
| 2021 | $2.74B | +13.3% |
| 2020 | $2.42B | -0.8% |
| 2019 | $2.44B | +6.1% |
| 2018 | $2.30B | +1.8% |
| 2017 | $2.26B | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $766.00M | +7.4% | +5.7% |
| June 30, 2025 | $725.00M | +3.9% | +1.3% |
| March 31, 2025 | $716.00M | +4.7% | +0.4% |
| September 30, 2024 | $713.00M | +6.1% | +2.1% |
| June 30, 2024 | $698.00M | -2.4% | +2.0% |
| March 31, 2024 | $684.00M | +4.6% | +1.8% |
| September 30, 2023 | $672.00M | -14.1% | -6.0% |
| June 30, 2023 | $715.00M | +4.5% | +9.3% |
- ABBOTT LABORATORIES showed an increase of +3.4% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, ABBOTT LABORATORIES’s r&d expense has grown by 30.2% (from $2.26 billion to $2.94 billion).
- The most recent figure is from ABBOTT LABORATORIES’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: